2027 project teams
The 2027 cohort of teams is tackling conditions ranging from heart attack and cardiac arrhythmias to acute brain injury, glaucoma, cirrhosis, and tooth decay, as well as overdose risk in residential addiction treatment and the limits of conventional MRI. Their innovations include a regenerative injectable hydrogel, wearable and ambient sensing systems, interpretable AI, a portable device for prehospital brain-injury care, an endoscopic pressure-measurement tool, a new approach to open MRI, and a new dental floss. Read the news announcement introducing the teams.
Amnova Biotech
New-generation technologies for cardiac regenerative therapy
Every 40 seconds, someone in the United States has a heart attack. Current treatments can restore blood flow and improve survival, but they cannot regenerate the cardiac tissue that has already been lost, which leaves many survivors at risk of developing heart failure. Amnova Biotech is developing a birth-tissue-inspired injectable hydrogel that delivers regenerative factors directly to the injured heart. It aims to promote tissue repair, preserve cardiac function, and prevent progression to heart failure.
DAISY
Dynamic Acquisition for open magnetic resonance Imaging SYstems
Conventional MRI leaves several medical needs unmet because of the narrow shape of the magnets required to ensure a highly homogeneous magnetic field. These include MRI-guided surgery, real-time image-guided radiotherapy, imaging of unsedated and uncooperative patients such as infants or people with claustrophobia, imaging of patients with obesity, low-bias functional imaging, and imaging of movement. These applications would require MRI with planar, open magnets whose magnetic fields are highly inhomogeneous, which makes conventional MRI impossible. DAISY aims to make this possible with a completely new encoding and decoding paradigm based on “acceleration” instead of “frequency”.
FASTer
Minimally invasive detection of acute brain injury
Acute brain injury is a major cause of patient morbidity and mortality, with outcomes often influenced by the critical time between injury onset and receiving appropriate treatment. Limitations in prehospital assessment can contribute to improper triage, resulting in life-altering delays as patients are redirected to facilities equipped to provide appropriate care. There is a pressing need to minimize secondary neurological injury during the prehospital period. We propose a portable, minimally invasive device designed to help mitigate neurological deterioration and improve patient outcomes, health-related quality of life (HRQoL), and the overall cost of care.
iECG
Cable-free cardiac monitoring with AI-powered automated arrhythmia detection
Cardiovascular disease is the leading cause of death globally, yet catching silent cardiac arrhythmias early remains a major clinical hurdle. Traditional Holter monitors are bulky, wired, and uncomfortable, which leads to poor patient compliance. Their offline data also requires manual downloads and hours of visual scanning, which creates severe diagnostic delays. iECG addresses this with a cloud-native, cable-free cardiac monitoring ecosystem. An ergonomic wearable continuously captures clinical-grade ECG signals, while AI-powered software automatically flags and timestamps arrhythmias upon cloud synchronization, helping cardiologists deliver faster diagnoses and making advanced preventive heart care more accessible.
MELX
Ambient sensing for behavioral health centers, residential addiction treatment, and senior facilities
Detecting presence, movement, and vital signs alerts caregivers to early warning signs. A centralized dashboard gives a big picture view of all the residents of large facilities, reduces documentation burden, and makes staff more effective at keeping people safe.
OCTai
Individual glaucoma progression risk from longitudinal OCT and clinical data
Glaucoma is a leading cause of irreversible blindness and is projected to affect 112 million people by 2040. Eye clinics follow it with optical coherence tomography (OCT), a retinal scan invented at MIT, but the scan’s software describes only damage already done. OCTai is developing interpretable artificial intelligence that forecasts, for each eye, the risk of significant progression within five years and where around the optic nerve it will happen, with reasons the ophthalmologist can review. The system will draw on about 30,000 routine scans from Portugal’s two largest hospitals and will be vendor-agnostic. It aims to outperform the scanner’s own trend analysis.
Portalyze
A low-cost, traceable device for EUS-guided portal pressure gradient measurement
Patients with cirrhosis who develop clinically significant portal hypertension face a high risk of life-threatening complications, a risk that treatment can reduce if the condition is detected early. Today, measuring portal pressure requires either an invasive catheter procedure available only in specialized centers or an expensive endoscopic kit with limited quality control. Portalyze is a low-cost device designed to let gastroenterologists measure portal pressure directly during endoscopic ultrasound, with built-in features that make each reading more reliable. The team is building and validating a prototype in bench and ex vivo models.
Thank You Floss
A unique approach to preventing cavities between teeth
Cavities are one of the most common chronic diseases in the world, and many of them start in the tight spaces between teeth where brushing can’t reach. Thank You Floss is a new dental floss formulated and built to give these hard-to-reach areas better protection. It works within the daily routine people already have, cleaning between teeth and adding extra protection against decay in one step. Same habit. Better defense!


